apa sensitive atcc plasmid par3 expression vector (ATCC)
99
Structured Review
ATCC
apa sensitive atcc plasmid par3 expression vector
Apa Sensitive Atcc Plasmid Par3 Expression Vector, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 20065 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apa+sensitive+atcc+plasmid+par3+expression+vector/Plasmid/pm21826554-54-3-4
Average 99 stars, based on 20065 article reviews
Apa Sensitive Atcc Plasmid Par3 Expression Vector, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 20065 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apa+sensitive+atcc+plasmid+par3+expression+vector/Plasmid/pm21826554-54-3-4
Average 99 stars, based on 20065 article reviews
apa sensitive atcc plasmid par3 expression vector - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Plasmid Preparation:Article Title: Developing an extended genomic engineering approach based on recombineering to knock-in heterologous genes to Escherichia coli genome. Article Snippet: Most existing genomic engineering protocols for manipulation of Escherichia coli are primarily focused on chromosomal gene knockout.. In this study, a simple but systematic chromosomal gene knock-in method was proposed based on a previously developed protocol using bacteriophage k (k Red) and flippase–flippase recognition targets (FLP–FRT) recombinations.. For demonstration purposes, DNA operons containing heterologous genes (i.e., pac encoding E. coli penicillin acylase and palB2 encoding Pseudozyma antarctica lipase B mutant) engineered with regulatory elements, such as strong/inducible promoters (i.e., Ptrc and ParaB), operators, and ribosomal binding sites, were integrated into the E. coli genome at designated locations (i.e., lacZYA, dbpA, and lacI-mhpR loci) either as a gene replacement or gene insertion using various antibiotic selection markers (i.e., kanamycin and chloramphenicol) under various genetic backgrounds (i.e., HB101 and DH5a). Expressing:Article Title: Developing an extended genomic engineering approach based on recombineering to knock-in heterologous genes to Escherichia coli genome. Article Snippet: Most existing genomic engineering protocols for manipulation of Escherichia coli are primarily focused on chromosomal gene knockout.. In this study, a simple but systematic chromosomal gene knock-in method was proposed based on a previously developed protocol using bacteriophage k (k Red) and flippase–flippase recognition targets (FLP–FRT) recombinations.. For demonstration purposes, DNA operons containing heterologous genes (i.e., pac encoding E. coli penicillin acylase and palB2 encoding Pseudozyma antarctica lipase B mutant) engineered with regulatory elements, such as strong/inducible promoters (i.e., Ptrc and ParaB), operators, and ribosomal binding sites, were integrated into the E. coli genome at designated locations (i.e., lacZYA, dbpA, and lacI-mhpR loci) either as a gene replacement or gene insertion using various antibiotic selection markers (i.e., kanamycin and chloramphenicol) under various genetic backgrounds (i.e., HB101 and DH5a). Polymerase Chain Reaction:Article Title: Developing an extended genomic engineering approach based on recombineering to knock-in heterologous genes to Escherichia coli genome. Article Snippet: Most existing genomic engineering protocols for manipulation of Escherichia coli are primarily focused on chromosomal gene knockout.. In this study, a simple but systematic chromosomal gene knock-in method was proposed based on a previously developed protocol using bacteriophage k (k Red) and flippase–flippase recognition targets (FLP–FRT) recombinations.. For demonstration purposes, DNA operons containing heterologous genes (i.e., pac encoding E. coli penicillin acylase and palB2 encoding Pseudozyma antarctica lipase B mutant) engineered with regulatory elements, such as strong/inducible promoters (i.e., Ptrc and ParaB), operators, and ribosomal binding sites, were integrated into the E. coli genome at designated locations (i.e., lacZYA, dbpA, and lacI-mhpR loci) either as a gene replacement or gene insertion using various antibiotic selection markers (i.e., kanamycin and chloramphenicol) under various genetic backgrounds (i.e., HB101 and DH5a). |